Ars Investment Partners, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ars Investment Partners, LLC

$976 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$144.95 - $152.29 $5.97 Million - $6.27 Million	41,175 Added 872.91%	45,892 $6.94 Million
Q2 2022 Jul 15, 2022	SELL	$83.14 - $145.99 $35.6 Million - $62.5 Million	-428,407 Reduced 98.91%	4,717 $687,000
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $3.33 Million - $4.33 Million	-30,268 Reduced 6.53%	433,124 $51.4 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $326,715 - $486,420	-3,276 Reduced 0.7%	463,392 $63.9 Million
Q3 2021 Nov 05, 2021	SELL	$98.85 - $138.91 $9.06 Million - $12.7 Million	-91,618 Reduced 16.41%	466,668 $64.8 Million
Q2 2021 Aug 06, 2021	SELL	$65.78 - $105.02 $207,601 - $331,443	-3,156 Reduced 0.56%	558,286 $54.2 Million
Q1 2021 May 13, 2021	BUY	$64.07 - $91.75 $128,460 - $183,958	2,005 Added 0.36%	561,442 $38.4 Million
Q4 2020 Feb 09, 2021	SELL	$65.07 - $98.24 $8,914 - $13,458	-137 Reduced 0.02%	559,437 $47.9 Million
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $2.7 Million - $3.56 Million	-45,668 Reduced 7.55%	559,574 $36.4 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $63,996 - $163,751	2,206 Added 0.37%	605,242 $44.2 Million
Q1 2020 May 12, 2020	BUY	$27.51 - $57.29 $488,219 - $1.02 Million	17,747 Added 3.03%	603,036 $20.5 Million
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $591,693 - $834,829	14,481 Added 2.54%	585,289 $31.9 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $993,747 - $1.32 Million	26,585 Added 4.88%	570,808 $23.8 Million
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $3.19 Million - $5.37 Million	80,096 Added 17.26%	544,223 $23.8 Million
Q1 2019 May 09, 2019	BUY	$34.52 - $53.29 $2.1 Million - $3.24 Million	60,856 Added 15.09%	464,127 $23.9 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $12 Million - $17.3 Million	403,271 New	403,271 $14.9 Million
Q3 2018 Nov 13, 2018	SELL	$32.79 - $43.0 $12.8 Million - $16.8 Million	-389,889 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$23.62 - $42.29 $3.06 Million - $5.48 Million	129,634 Added 49.81%	389,889 $15.4 Million
Q1 2018 May 04, 2018	BUY	$22.49 - $34.56 $3.46 Million - $5.32 Million	153,943 Added 144.8%	260,255 $6.7 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $2.17 Million - $3.78 Million	106,312	106,312 $2.87 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.

Account